Euclises Pharmaceuticals' Series A Round

Euclises Pharmaceuticals raised a round of funding on September 09, 2014.

Euclises Pharmaceuticals (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio…

Articles about Euclises Pharmaceuticals' Series A Round: